Jagsonpal Pharmaceuticals Limited (BOM:507789)

Jagsonpal Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	12,964	14,422	7,313	7,592	8,214	2,085
Market Cap Growth	-30.32%	97.22%	-3.68%	-7.58%	293.91%	353.56%
Enterprise Value	11,460	13,741	6,290	7,175	7,748	1,574
Last Close Price	193.50	213.78	109.49	112.18	121.35	29.87
PE Ratio	20.93	26.05	32.55	28.41	43.57	12.23
PS Ratio	4.59	5.37	3.50	3.21	3.78	1.11
PB Ratio	5.13	6.01	3.90	4.78	6.19	1.71
P/TBV Ratio	7.58	9.35	3.90	4.78	6.19	1.71
P/FCF Ratio	32.35	26.24	20.94	16.39	140.06	7.51
P/OCF Ratio	32.18	26.08	20.80	16.27	118.81	7.39
EV/Sales Ratio	4.05	5.11	3.01	3.03	3.56	0.84
EV/EBITDA Ratio	20.76	27.69	28.44	20.67	30.37	7.92
EV/EBIT Ratio	25.06	32.00	29.11	21.18	32.30	8.38
EV/FCF Ratio	28.60	25.01	18.01	15.49	132.10	5.67
Debt / Equity Ratio	0.04	0.04	0.05	0.04	-	0.06
Debt / EBITDA Ratio	0.16	0.18	0.38	0.17	-	0.34
Debt / FCF Ratio	0.22	0.17	0.26	0.13	-	0.25
Asset Turnover	1.01	1.09	1.01	1.32	1.33	1.20
Inventory Turnover	6.31	6.42	4.52	3.68	3.02	2.75
Quick Ratio	5.47	5.48	8.31	4.92	2.32	1.89
Current Ratio	6.07	6.22	10.29	5.97	4.04	2.98
Return on Equity (ROE)	27.53%	25.91%	12.97%	18.32%	14.81%	14.64%
Return on Assets (ROA)	10.26%	10.84%	6.55%	11.79%	9.13%	7.51%
Return on Capital (ROIC)	12.20%	12.05%	7.48%	14.23%	11.47%	9.54%
Return on Capital Employed (ROCE)	17.20%	17.00%	10.90%	20.20%	17.50%	15.20%
Earnings Yield	4.78%	3.84%	3.07%	3.52%	2.30%	8.18%
FCF Yield	3.09%	3.81%	4.78%	6.10%	0.71%	13.31%
Dividend Yield	1.26%	1.17%	1.83%	1.78%	1.32%	1.34%
Payout Ratio	26.89%	23.90%	58.31%	-	55.58%	15.36%
Buyback Yield / Dilution	-0.41%	-1.56%	-1.23%	-	-	-
Total Shareholder Return	0.85%	-0.39%	0.60%	1.78%	1.32%	1.34%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.